Asia Pacific Synthetic Biology Market size was valued at US$ 1.6 Bn. in 2021 and the total Asia Pacific Synthetic Biology Market revenue is expected to grow at 27 % from 2021 to 2029, reaching nearly US$ 10.9 Bn.
Asia Pacific Synthetic Biology Market Overview:Molecular biology, biotechnology, biophysics, and genetic engineering, among other fields, are all incorporated into the innovative field of study known as synthetic biology. In synthetic biology, the top down approach and bottom up approach are primarily employed. Redesigning and creating new biological systems to produce synthetic goods is a top-down strategy. A bottom-up strategy entails inventing and creating biological systems or gadgets from scratch that do not already exist in nature. To know about the Research Methodology:-Request Free Sample Report The creation of the synthetic biology business is a result of the urgent need to comprehend how genetic components, cells, and biological processes work. The pharmaceutical and diagnostic, energy, bioplastics, and environmental industries all employ the products created in this novel biological system. Using secondary research, we first gathered information on the key suppliers' revenue in order to evaluate and forecast the market for unified monitoring. To divide the market into segments, by Products (Synthetic Genes, Synthetic DNA , Synthetic Oligos, Software Tools, Chassis Organisms, Synthetic Clones, Synthetic Cells) by Technology (Nucleotide Synthesis And Sequencing, Bioinformatics, Microfluidics, Genetic Engineering) by Application (Pharmaceuticals & Diagnostics, Chemicals, Biofuels, Bioplastics, Others) vendors' offerings are taken into account. After that, these components were verified through primary research by speaking in-depth with influential people, such as chief executive officers (CEOs), vice presidents (VPs), directors, and executives. In order to estimate the market size, top-down and bottom-up methods are employed. Primary and secondary research are used to identify the major players in the Asia Pacific Synthetic Biology Market and to calculate their market revenues. In contrast to secondary research, which required examining the annual and financial reports of the leading manufacturers, primary research involved conducting interviews with major opinion leaders and business leaders in the industry, including CEOs and marketing executives. Thermo Fisher Scientific Inc., Integrated DNA Technologies, Inc., Synthetic Genomics Inc.,Genscript Corporation, Amyris, Intrexon is a few of the top significant competitors in the Asia Pacific Synthetic Biology Market For the duration of the forecast period, they are continually strategizing about mergers and acquisitions to increase their market shares and growth potential.
Asia Pacific Synthetic Biology Market Dynamics:Market Drivers: Pharmaceutical companies now receive more funds for research and development in order to create new therapies. Government measures to fund various pharma and biotech enterprises have been taken in order to advance pharmaceutical research and boost asia pacific competitiveness. This has led to a consistent rise in R&D investment and spending over time. Pharmaceutical and biotechnology businesses make significant investments in research to create ground-breaking compounds that meet the growing demands of the healthcare sector and find cures for novel diseases. More than 80% of all R&D expenditures in the life sciences sector are made up by the worldwide pharmaceutical R&D sector. Market Restraints: The deliberate or accidental release of synthetic organisms into the environment for research and other reasons is the main biosafety problem in synthetic biology. When artificial microorganisms are released into the environment, they have the potential to mutate or interact with other organisms, which could lead to cross-breeding with real creatures and the development of bio mistakes. The ecosystem of living things may be in danger as a result of these effects. A significant biosafety problem is the development of superbugs resistant to antibiotics. The European Union (EU) has recently supported a number of studies on the environmental effects of intentionally releasing genetically modified microorganisms for plant growth or bioremediation. These elements could limit market expansion in the ensuing years. Market Opportunities: The main participants in the synthetic biology sector are concentrating on creating automatic fixes for tools and machinery utilized in the operations. The method can be automated to increase efficiency and consistency throughout the entire diagnostic procedure. Diagnostic procedures that are computerized produce trustworthy and effective test findings as opposed to manual testing by different experts. The Oral Fluid Nano Sensor Test is used by the industry's participants and is based on nanotechnology (OFNASET). For the purpose of detecting oral cancer indicators in saliva, the test makes use of a microfluidic-based nanosensor. Roche developed cobas connection modules (CCM) to increase scalability and sample-flow efficiency by enabling samples to travel automatically between various systems and equipment in order to stay up with the trend of automation and accuracy. Establishing a workflow that is entirely automated. Companies in the synthetic biology market are concentrating on the creation of automated tools for COVID-19 testing, nucleotide synthesis, and sequencing devices. As a result, the entire sequencing process will be more efficient and consistent, and there will be fewer touch points for handling samples, consumables, and liquids, improving the safety of the clinical and laboratory staff. Automation speeds up the process, lowers mistake rates, and improves the number of tests that are run each day.
Asia Pacific Synthetic Biology Market Segment Analysis:Based on Product, The Synthetic Genes segment is expected to grow at the highest CAGR during the forecast period. Owing to the rising demand for synthetic DNA, synthetic RNA, and oligonucleotides across a variety of application industries, the Synthetic genes segment entered the market in 2020 and is expected to grow at a profitable rate throughout the forecast period. Genome engineering benefits greatly from gene synthesis, which increases its appeal and worth. Gene synthesis is severely restricted in effective genomic targeting and editing. Additionally, the industry is growing because to increased financing for genetics, a focus on personalised treatment, and other factors like a patient-centered approach. Based on Technology, The Nucleotide Synthesis & Sequencing segment is expected to grow at the highest CAGR during the forecast period. Finding the nucleotide synthesis & sequencing, or the order of nucleotides in DNA, is the process of DNA sequencing. The four bases—adenine, guanine, cytosine, and thymine—are arranged in this way using any technique or technology. Rapid DNA sequencing techniques have substantially expedited the study of biology and medicine. For basic biological research, DNA Genographic Projects, and many applied sectors like medical diagnosis, biotechnology, forensic biology, virology, and biological systematics, knowledge of DNA sequences has become essential. In order to identify various illnesses, such as different malignancies, characterize the antibody repertoire, characterize healthy and altered DNA sequences, and can be used to direct patient treatment. The ability to quickly sequence DNA enables the identification and cataloguing of more organisms as well as the provision of quicker and more tailored medical care. Based on Application, The Pharmaceuticals & Diagnostics segment is expected to grow at the highest CAGR during the forecast period. To find ground-breaking drugs that can battle new ailments and meet the escalating demands of the healthcare sector, pharmaceutical and biotechnology companies invest a lot of money in research. Rising research and development efforts on synthetic pharmaceuticals and vaccines will also offer industry participants significant growth prospects. Furthermore, new market entrants and start-ups are finding success thanks to technology developments in the healthcare industry and sophisticated healthcare infrastructure. Additionally, a wide range of industries are using synthetic biology-related products and technologies extensively. In China, the need for synthetic biology techniques is growing as a result of the low cost of the organisms created using these techniques thanks to their employment in a variety of commercial applications that cut down on research expenses. To obtain a competitive edge over the market, the top competitors are employing a variety of techniques. Partnerships, acquisitions, and mergers are some of the strategies. A big concern for the Asia pacific synthetic biology market would still be matters like the misuse of synthetic biology or the possibility of viruses being unintentionally discharged into the open atmosphere.
Asia Pacific Synthetic Biology Market Regional Insights:The presence of major industry players involved in R&D and growing government backing are what are driving the market in the asia pacific region. The rising involvement of governmental organizations, academic institutions, and significant businesses in synthetic biology research is expected to boost the market in the forecast years. The market for synthetic biology in China is expected to acquire the largest share in the APAC market throughout the forecast period. This is owing to the fact that China has seen technical developments in the healthcare industry. However, the establishment of small start-ups and investments by the main leading corporations, particularly in the biofuel category, is expected to accelerate market growth. One of the markets in APAC with the highest growth is the Indian synthetic biology market. As a result, it is expected that the Indian Synthetic Biology Market grow significantly and contribute to the APAC regional market. Additionally, market growth is supported by favourable government regulations, rising investments, and the use of contemporary synthetic biology technologies. The objective of the report is to present a comprehensive analysis of the Asia Pacific Synthetic Biology Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Asia Pacific Synthetic Biology Market dynamics, structure by analyzing the market segments and project the Asia Pacific Synthetic Biology Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Asia Pacific Synthetic Biology Market make the report investor’s guide.
Asia Pacific Synthetic Biology Market Scope: Inquire before buying
Asia Pacific Synthetic Biology Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 1.6 Bn. Forecast Period 2022 to 2029 CAGR: 27 % Market Size in 2029: US $ 10.9 Bn. Segments Covered: by Product • Synthetic Genes • Synthetic DNA • Synthetic Oligos • Software Tools • Chassis Organisms • Synthetic Clones • Synthetic Cells by Technology • Nucleotide Synthesis & Sequencing • Bioinformatics • Microfluidics • Genetic Engineering by Application • Pharmaceuticals & Diagnostics • Chemicals • Biofuels • Bioplastics • Others
Asia Pacific Synthetic Biology Market, by Region• China • India • Japan • Others
Asia Pacific Synthetic Biology Market Key Players• Thermo Fisher Scientific Inc. • Integrated DNA Technologies, Inc. • Synthetic Genomics Inc. • Genscript Corporation • Amyris • Intrexon • Dupont • Agilent Technologies • Novozymes • Origene Technologies, Inc. • Royal DSM N. V. • New England Biolabs, Inc. • Autolus Therapeutics PLC • Butamax Advanced Biofuels LLC • Desktop Genetics, Ltd. • E. I. du Pont de Nemours and Co. • LGC, Ltd. • Merck KGaA • Twist Bioscience Corp. FAQs: 1. Which is the potential market for the Asia Pacific Synthetic Biology Market in terms of the region? Ans. In China region, the growing business and educational sectors are expected to help drive the use of collaborative screens. 2. What are the opportunities for new market entrants? Ans. The key opportunity in the market is new initiatives from governments that provide funding for Asia Pacific Synthetic Biology Markets in educational institutes 3. What is expected to drive the growth of the Asia Pacific Synthetic Biology Market in the forecast period? Ans. A major driver in the Asia Pacific Synthetic Biology Market is the prevalence of work from home and remote collaboration created by the COVID-19 pandemic 4. What is the projected market size & growth rate of the Asia Pacific Synthetic Biology Market? Ans. Asia Pacific Synthetic Biology Market size was valued at US$ 1.3 Billion in 2020 and the total Asia Pacific Synthetic Biology Market revenue is expected to grow at 27 % through 2021 to 2029, reaching nearly US$ 10.9 Billion. 5. What segments are covered in the Asia Pacific Synthetic Biology Market report? Ans. The segments covered are by Product, Technology, Application and, Region.
1. Asia Pacific Synthetic Biology Market Size: Research Methodology 2. Asia Pacific Synthetic Biology Market Size: Executive Summary 2.1. Market Overview and Definitions 2.1.1. Introduction to Asia Pacific Synthetic Biology Market Size 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Asia Pacific Synthetic Biology Market Size: Competitive Analysis 3.1. MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2. Consolidation in the Market 3.2.1 M&A by region 3.3. Key Developments by Companies 3.4. Market Drivers 3.5. Market Restraints 3.6. Market Opportunities 3.7. Market Challenges 3.8. Market Dynamics 3.9. PORTERS Five Forces Analysis 3.10. PESTLE 3.11. Regulatory Landscape by region • China • India • Japan • Others 3.12. COVID-19 Impact 4. Asia Pacific Synthetic Biology Market Size Segmentation 4.1. Asia Pacific Synthetic Biology Market Size, by Product (2021-2029) • Synthetic Genes • Synthetic DNA • Synthetic Oligos • Software Tools • Chassis Organisms • Synthetic Clones • Synthetic Cells 4.2. Asia Pacific Synthetic Biology Market Size, by Technology (2021-2029) • Nucleotide Synthesis And Sequencing • Bioinformatics • Microfluidics • Genetic Engineering 4.3. Asia Pacific Synthetic Biology Market Size, by Application (2021-2029) • Pharmaceuticals & Diagnostics • Chemicals • Biofuels • Bioplastics • Others 5. China Asia Pacific Synthetic Biology Market (2021-2029) 5.1. China Asia Pacific Synthetic Biology Market Size, by Product (2021-2029) • Synthetic Genes • Synthetic DNA • Synthetic Oligos • Software Tools • Chassis Organisms • Synthetic Clones • Synthetic Cells 5.2. China Asia Pacific Synthetic Biology Market Size, by Technology (2021-2029) • Nucleotide Synthesis And Sequencing • Bioinformatics • Microfluidics • Genetic Engineering 5.3. China Asia Pacific Synthetic Biology Market Size, by Application (2021-2029) • Pharmaceuticals & Diagnostics • Chemicals • Biofuels • Bioplastics • Others 5.4. China Asia Pacific Synthetic Biology Market, by Country (2021-2029) • China • India • Japan • Others 6. India Asia Pacific Synthetic Biology Market (2021-2029) 6.1. India Asia Pacific Synthetic Biology Market, by Product (2021-2029) 6.2. India Asia Pacific Synthetic Biology Market, by Technology (2021-2029) 6.3. India Asia Pacific Synthetic Biology Market, by Application (2021-2029) 6.4. India Asia Pacific Synthetic Biology Market, by Country (2021-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Company Profile: Key players 7.1. Thermo Fisher Scientific Inc. 7.1.1. Company Overview 7.1.2. Financial Overview 7.1.3. Presence 7.1.4. Capacity Portfolio 7.1.5. Business Strategy 7.1.6. Recent Developments 7.2. Integrated DNA Technologies, Inc. 7.3. Synthetic Genomics Inc. 7.4. Genscript Corporation 7.5. Amyris 7.6. Intrexon 7.7. Dupont 7.8. Agilent Technologies 7.9. Novozymes 7.10. Origene Technologies, Inc. 7.11. Royal DSM N. V. 7.12. New England Biolabs, Inc. 7.13. Autolus Therapeutics PLC 7.14. Butamax Advanced Biofuels LLC 7.15. Desktop Genetics, Ltd. 7.16. E. I. du Pont de Nemours and Co. 7.17. LGC, Ltd. 7.18. Merck KGaA 7.19. Twist Bioscience Corp.